Piramal Enterprises (Delisted) share news and announcements
BSE: 500302Finance
Formerly Piramal Healthcare
Last traded ₹1,124.20 on 22 Sep 2025
Delisted on 16 Jan 2026.
Piramal Enterprises share news and announcements
3,280 announcements, routine notices left out, newest first. Page 59 of 66.
Sep 2011
Aug 2011
17 Aug · Meeting
Annual General Meeting of the members of the Company held on August 09, 2011 has approved the following: (1) The Audited Accounts for the year ended March 31, 2011 were adopted. (2) Dividend at Rs. 12/- per equity share of Rs.2/- (i.e. @ 600%) on 16,72,10,515 Equity Shares was declared for the financial year ended March 31, 2011. (3) Mr. Y. H. Malegam and Mr. Deepak Satwalekar have been reappointed as Directors of the Company. (4) M/s. Price Waterhouse, Chartered Accountants, Mumbai have been reappointed as Auditors of the Company. (5) Mr. Amit Chandra has been appointed as Director of the Company.16 Aug · Meeting
At the 64th Annual General Meeting of the Company which was held on August 09, 2011, all the businesses mentioned in the Notice convening the ....11 Aug · Piramal Healthcare to acquire 5.5% stake in Vodafone Essar
2 Aug · Results
Consolidated Results for the quarter ended on 30-JUN-2011 as follows: Net Sales of Rs. 44098 lacs for quarter ending on 30-JUN-2011 against Rs. 84241 lacs for the quarter ending on 30-JUN-2010. Net Profit / (Loss) of Rs. 8923 lacs for the quarter ending on 30-JUN-2011 against Rs. 8074 lacs for the quarter ending on 30-JUN-2010.2 Aug · Results
Standalone Results for the quarter ended on 30-JUN-2011 as follows: Net Sales of Rs. 25550 lacs for quarter ending on 30-JUN-2011 against Rs. 57036 lacs for the quarter ending on 30-JUN-2010. Net Profit / (Loss) of Rs. 10109 lacs for the quarter ending on 30-JUN-2011 against Rs. 6691 lacs for the quarter ending on 30-JUN-2010.
Jul 2011
22 Jul · Board meeting
To consider and take on record the Unaudited Financial Results (consolidated and standalone) of the Company for the 1st Quarter ended June 30, 2011. The results shall be subjected to limited review.22 Jul · Results
Meeting of the Board of Directors of the Company will be held on August 02, 2011, inter alia, to consider and take on record the Unaudited ....
Jun 2011
21 Jun · Management
Mr. Amit Chandra has been appointed as an Additional Director on the Board of the Company.9 Jun · Meeting
Register of Members & Share Transfer Books of the Company will remain closed from August 01, 2011 to August 09, 2011 (both days inclusive) ....
May 2011
6 May · Board meeting
Board of Directors of the Company at its meeting held on May 06, 2011, inter alia, has taken the following decisions : 1. The Board ....6 May · Dividend
Board of Directors of the Company at its meeting held on May 06, 2011, inter alia, has taken the following decision: 1. The Board ....6 May · Board meeting
6 May · Dividend
Board of Directors of the Company at its meeting held on May 06, 2011 has recommended dividend of Rs.6 per equity share of face value of Rs.2/- (i.e. @ 300%) for the financial year ended March 31, 2011. In addition to this, the Board has also recommended a one-time Special Dividend of Rs.6 per equity share of face value of Rs.2/- (i.e. @ 300%) as a further reward to shareholders consequent to the sale of the Domestic Formulations Business which took place during the financial year ended March 31, 2011. The total dividends (i.e. normal dividend and one-time special dividend, as aforesaid) recommended by the Board therefore aggregates to Rs.12 per equity share of face value of Rs.2/- (i.e. @ 600%), which when declared at the Annual General Meeting (AGM), will be paid within 5 days from the AGM date.6 May · Results
Consolidated Results for the year ended on 31-MAR-2011 as follows: Net Sales of Rs. 250986 lacs for year ending on 31-MAR-2011 against Rs. 367105 lacs for the year ending on 31-MAR-2010. Net Profit / (Loss) of Rs. 1288336 lacs for the year ending on 31-MAR-2011 against Rs. 48190 lacs for the year ending on 31-MAR-2010.6 May · Results
Standalone Results for the year ended on 31-MAR-2011 as follows: Net Sales of Rs. 158536 lacs for year ending on 31-MAR-2011 against Rs. 266621 lacs for the year ending on 31-MAR-2010. Net Profit / (Loss) of Rs. 1289691 lacs for the year ending on 31-MAR-2011 against Rs. 44322 lacs for the year ending on 31-MAR-2010.4 May · Board Meeting on May 06, 2011
Meeting of the Board of Directors of the Company will be held on May 06, 2011, for considering a proposal for Demerger of the New Chemical ....
Apr 2011
27 Apr · Board meeting
(1) To consider and approve the Audited Financial Results (consolidated & stand-alone) of the Company for the financial year ended March 31, 2011; (2) To consider recommendation of dividend on the equity shares of the Company for the financial year ended March 31, 2011.27 Apr · Results
Meeting of the Board of Directors of the Company will be held on May 06, 2011, to consider and approve the Audited Financial Results (consolidated ....15 Apr · Clarifies on News Item
With reference to the news item appearing in a leading financial daily titled "Piramal, Sunteck close to Mafatlal land buy", Piramal Healthcare Ltd has clarified to BSE that the said news ....15 Apr · News Verification
News Verification : The media had reports that Piramal Healthcare Limited may buy Mafatlal Industries Limited's 7 acre plot in Central Mumbai. The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Piramal Healthcare Limited has vide its letter inter-alia stated, "We would like to clarify that the said news article does not pertain at all to the Company. The Company is not buying any land from Mafatlal Industries Limited."1 Apr · Post Buyback Public Announcement